Three out of the five patients 60% who underwent CE in the first 48 hours had significant findings P2, seven out of thirteen 54% who underwent CE between 48 hours and 7 days later had significant findings P2, four out of six 67% who underwent CE between 7 and 30 days later had significant findings P2, two out of the three patients 67% who underwent CE 30 days after the bleeding episode had significant findings P2.
Se encontraron hallazgos significativos P2 en 3/5 pacientes 60% a quienes se les realizó CE en las primeras 48 horas, 7/13 54% entre 48 horas y 7 días, 4/6 67% entre 7 y 30 días, y por último en 2/3 pacientes 67%, después de 30 días del episodio de sangrado.